XML 37 R26.htm IDEA: XBRL DOCUMENT

Cash and Marketable Securities (Tables)

3 Months Ended

Mar. 31, 2025

Cash and Cash Equivalents [Abstract]

Summary of Reconciliation of Cash and Cash Equivalents

A reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the amount reported within the condensed consolidated statements of cash flows is shown in the table below (in thousands):


	March 31, 2025		March 31, 2024
Cash and cash equivalents	$	88,745	$	93,299
Restricted cash	550		583
Total cash, cash equivalents and restricted cash at the end of the period	$	89,295	$	93,882

Summary of Marketable Securities

The amortized cost, unrealized holding gains and fair value of the Company’s marketable securities by major security type at each balance sheet date are summarized in the tables below (in thousands):


	March 31, 2025
	Amortized Cost		Unrealized Holding Gains, Net		Fair Value
Short-term marketable securities:
United States ("U.S.") agency securities	$	90,700	$	546	$	91,246
Corporate debt securities	51,472		763		52,235
Total short-term marketable securities	$	142,172	$	1,309	$	143,481


	December 31, 2024
	Amortized Cost		Unrealized Holding Gains, Net		Fair Value
Short-term marketable securities:
U.S. agency securities	$	90,918	$	1,648	$	92,566
Corporate debt securities	55,046		718		55,764
Total short-term marketable securities	$	145,964	$	2,366	$	148,330